World's Best Scientists 2026 revealed!
Ken Shirabe

Ken Shirabe

D-Index & Metrics

Medicine

D-Index
88
Citations
39008
World Ranking
12954
National Ranking
380

Ken Shirabe publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Ken Shirabe sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 935 publications — 92nd percentile

92% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Ken Shirabe D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Ken Shirabe sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 88 D-Index — 36th percentile

36% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Ken Shirabe is affiliated with Gunma University in Japan and has an extensive body of research mainly focused on medicine, with particular contributions in surgery, oncology, pulmonary and respiratory medicine, molecular biology, and hepatology. Their publication record reflects a strong engagement in clinical and experimental cancer research.

The scientist's recent publications cover several aspects of cancer biology and treatment. Notable papers include:

  • High L-Type Amino Acid Transporter 1 Levels Are Associated with Chemotherapeutic Resistance in Gastric Cancer Patients (2021, Oncology)
  • Nintedanib inhibits intrahepatic cholangiocarcinoma aggressiveness via suppression of cytokines extracted from activated cancer-associated fibroblasts (2020, British Journal of Cancer)
  • Diagnostic value of 18F-FDG-PET to predict the tumour immune status defined by tumoural PD-L1 and CD8+tumour-infiltrating lymphocytes in oral squamous cell carcinoma (2020, British Journal of Cancer)
  • Implications of Low Serum Albumin as a Prognostic Factor of Long-term Outcomes in Patients With Breast Cancer (2020, In Vivo)
  • Targetable ERBB2 mutation status is an independent marker of adverse prognosis in estrogen receptor positive, ERBB2 non-amplified primary lobular breast carcinoma: a retrospective in silico analysis of public datasets (2020, Breast Cancer Research)

Ken Shirabe frequently collaborates with several coauthors, indicating a broad collaborative network in their research endeavors. The top collaborators include:

  • Makoto Sohda (115 joint publications)
  • Takehiko Yokobori (99 joint publications)
  • Akihiko Sano (93 joint publications)
  • Hiroomi Ogawa (88 joint publications)
  • Makoto Sakai (87 joint publications)

The scientist's works have been published in a variety of academic journals, with repeated contributions to the following publication venues:

  • Anticancer Research (28 publications)
  • Surgical Case Reports (27 publications)
  • Annals of Surgical Oncology (22 publications)
  • Surgery Today (18 publications)
  • Annals of Gastroenterological Surgery (17 publications)

Ken Shirabe's research spans several main fields and related subfields, highlighting a focus on surgical and oncological areas particularly relevant to cancer management:

  • Main field: Medicine (868 publications)
  • Subfields: Surgery (210), Oncology (200), Pulmonary and Respiratory Medicine (172), Molecular Biology (59), Hepatology (53)

The primary research topics explored by Ken Shirabe include key domains of cancer and related conditions, reflecting a multidisciplinary approach to disease management and prognosis:

  • Gastric Cancer Management and Outcomes (92 publications)
  • Pancreatic and Hepatic Oncology Research (84 publications)
  • Esophageal Cancer Research and Treatment (74 publications)
  • Cancer Immunotherapy and Biomarkers (70 publications)
  • Hepatocellular Carcinoma Treatment and Prognosis (64 publications)
  • Esophageal and GI Pathology (58 publications)
  • Nutrition and Health in Aging (50 publications)

Best Publications

  • Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

    Daniel J. Klionsky;Kotb Abdelmohsen;Akihisa Abe;Joynal Abedin

  • Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

    Daniel J. Klionsky;Kotb Abdelmohsen;Akihisa Abe;Joynal Abedin

  • Postoperative liver failure after major hepatic resection for hepatocellular carcinoma in the modern era with special reference to remnant liver volume

    Ken Shirabe;Mitsuo Shimada;Tomonobu Gion;Hirofumi Hasegawa

  • Sarcopenia as a predictor of prognosis in patients following hepatectomy for hepatocellular carcinoma

    N. Harimoto;K. Shirabe;Y. I. Yamashita;Toru Ikegami

  • Neutrophil–lymphocyte ratio reflects hepatocellular carcinoma recurrence after liver transplantation via inflammatory microenvironment

    Takashi Motomura;Ken Shirabe;Yohei Mano;Jun Muto

  • Bile Leakage After Hepatic Resection

    Yo Ichi Yamashita;Takayuki Hamatsu;Tatsuya Rikimaru;Shinji Tanaka

  • Factors linked to early recurrence of small hepatocellular carcinoma after hepatectomy: Univariate and multivariate analyses

    Ken Shirabe;Takashi Kanematsu;Takashi Matsumata;Eisuke Adachi

  • Preoperative neutrophil-to-lymphocyte ratio is a predictor of survival after hepatectomy for hepatocellular carcinoma: a retrospective analysis.

    Yohei Mano;Ken Shirabe;Yo Ichi Yamashita;Norifumi Harimoto

  • Risk factors for intrahepatic recurrence in human small hepatocellular carcinoma.

    Eisuke Adachi;Takashi Maeda;Takashi Matsumata;Ken Shirabe

  • Sarcopenia is a prognostic factor in living donor liver transplantation

    Toshiro Masuda;Ken Shirabe;Toru Ikegami;Norifumi Harimoto

  • Identification of a bona fide microRNA biomarker in serum exosomes that predicts hepatocellular carcinoma recurrence after liver transplantation

    K Sugimachi;T Matsumura;H Hirata;R Uchi

  • Genome-wide association study identifies TNFSF15 and POU2AF1 as susceptibility loci for primary biliary cirrhosis in the Japanese population.

    Minoru Nakamura;Nao Nishida;Minae Kawashima;Yoshihiro Aiba

  • Results of 280 Liver Resections for Hepatocellular Carcinoma

    Kenji Takenaka;Naoyuki Kawahara;Kazuharu Yamamoto;Kiyoshi Kajiyama

  • Prognosis of Recurrent Hepatocellular Carcinoma: A 10-Year Surgical Experience in Japan

    Mitsuo Shimada;Kenji Takenaka;Tomonobu Gion;Yuh Fujiwara

  • Erratum to: Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) (Autophagy, 12, 1, 1-222, 10.1080/15548627.2015.1100356

    Daniel J. Klionsky;Kotb Abdelmohsen;Akihisa Abe;Joynal Abedin

  • Variants in IL28B in liver recipients and donors correlate with response to peg-interferon and ribavirin therapy for recurrent hepatitis C.

    Takasuke Fukuhara;Akinobu Taketomi;Takashi Motomura;Shinji Okano

  • The predictors of microvascular invasion in candidates for liver transplantation with hepatocellular carcinoma-with special reference to the serum levels of des-gamma-carboxy prothrombin.

    Ken Shirabe;shinji itoh;Tomoharu Yoshizumi;Yuji Soejima

  • Trends in morbidity and mortality after hepatic resection for hepatocellular carcinoma: an institute's experience with 625 patients.

    Akinobu Taketomi;Dai Kitagawa;Shinji Itoh;Norifumi Harimoto

  • Electroporation-mediated Interleukin-12 Gene Therapy for Hepatocellular Carcinoma in the Mice Model

    Yo-ichi Yamashita;Mitsuo Shimada;Hirofumi Hasegawa;Ryosuke Minagawa

  • Value of lymph node dissection during resection of intrahepatic cholangiocarcinoma

    M Shimada;Y Yamashita;S Aishima;K Shirabe

Frequent Co-Authors

Yoshihiko Maehara
Yoshihiko Maehara Kyushu University
Akinobu Taketomi
Akinobu Taketomi Hokkaido University
Mitsuo Shimada
Mitsuo Shimada University of Tokushima
Hiroyuki Kuwano
Hiroyuki Kuwano Gunma University
Keizo Sugimachi
Keizo Sugimachi Kyushu University
Yoshinao Oda
Yoshinao Oda Kyushu University
Hiroshi Honda
Hiroshi Honda Kyushu University
Hideo Baba
Hideo Baba Kumamoto University
Shinji Shimoda
Shinji Shimoda Kyushu University
Koshi Mimori
Koshi Mimori Kyushu University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring alternative pathways in healthcare can diversify your career after studying Medicine in the USA. Many professionals consider advanced online degrees for flexibility and accessibility, especially if balancing work or personal commitments.

For those interested in hospital administration or leadership, earning an MHA online is a popular option. You can review a cahme accredited online mha programs list to ensure your program is recognized and meets high standards for healthcare management education.

Registered nurses seeking to advance their qualifications may benefit from bridge programs, such as rn to bsn no clinical hours options. These pathways allow working professionals to complete their bachelor’s without onsite clinical requirements.

Nurses aiming for the highest clinical roles should consider doctoral programs. Look into accelerated msn to dnp programs for an efficient transition, or find a cheapest dnp program to minimize expenses while maximizing clinical impact. These options streamline your journey toward advanced nursing practice and leadership.

Best Scientists Citing Ken Shirabe

Trending Scientists

Recently Published Articles